First Mercantile Trust’s Array Biopharma Inc ARRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-9,924
Closed -$460K 974
2019
Q2
$460K Sell
9,924
-9,838
-50% -$276K 0.05% 227
2019
Q1
$481K Buy
19,762
+1,010
+5% +$21K 0.11% 215
2018
Q4
$267K Sell
18,752
-8,723
-32% -$132K 0.06% 341
2018
Q3
$418K Buy
27,475
+775
+3% +$11.9K 0.08% 292
2018
Q2
$448K Buy
26,700
+7,332
+38% +$117K 0.09% 277
2018
Q1
$316K Buy
19,368
+5,146
+36% +$82.4K 0.07% 357
2017
Q4
$182K Buy
+14,222
New +$162K 0.04% 567
2017
Q2
Sell
-8,930
Closed -$80K 876
2017
Q1
$80K Sell
8,930
-795
-8% -$8.46K 0.01% 764
2016
Q4
$85K Sell
9,725
-4,475
-32% -$32.9K 0.01% 768
2016
Q3
$96K Buy
+14,200
New +$54.9K 0.01% 729
2014
Q1
Sell
-5,647
Closed -$28K 1320
2013
Q4
$28K Sell
5,647
-1,965
-26% -$10.7K ﹤0.01% 1064
2013
Q3
$47K Sell
7,612
-1,540
-17% -$9.15K ﹤0.01% 987
2013
Q2
$42K Buy
+9,152
New +$49.2K ﹤0.01% 997

Other funds holding ARRY

First Mercantile Trust's ARRY Position: Q3 2019 in Review

First Mercantile Trust sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 9,924 shares — an estimated $460K sold.

First Mercantile Trust first reported a position in ARRY in Q2 2013 and held it in 13 quarters. The position peaked at $481K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • First Mercantile Trust reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • First Mercantile Trust sold 9,924 Array Biopharma Inc shares in Q3 2019, an estimated $460K.
  • First Mercantile Trust first reported a position in Array Biopharma Inc in Q2 2013 and held it in 13 quarters.
  • First Mercantile Trust's Array Biopharma Inc position peaked at $481K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on First Mercantile Trust's 13F filing for Q3 2019, filed 1 Nov 2019.